Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Valeant Pharmaceuticals International Inc Says May Cut 10%-15% Jobs After Bausch & Lomb Deal-Reuters


Monday, 29 Jul 2013 06:56am EDT 

Reuters reported that Valeant Pharmaceuticals International Inc, which has offered to buy Bausch & Lomb Holdings for $8.7 billion, said it may slash 10% to 15% of the combined company's workforce. Valeant, which expects to get regulatory nod by early August, said severance plans for the United States and Canada have been finalized. 

Company Quote

123.7
0.17 +0.14%
29 Jul 2014